Pliant Therapeutics, Inc. (NASDAQ: PLRX) reported Q4 EPS of ($0.38), $0.01 better than the analyst estimate of ($0.39).

For earnings history and earnings-related data on Pliant Therapeutics, Inc. (PLRX) click here.